Feline Toxoplasmosis: Zoonotic Implications and Clinical Management

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a complex life cycle involving definitive felid hosts and a wide range of intermediate hosts [1, 2]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [3]. Felids, including domestic cats, are the only definitive hosts capable of shedding oocysts into the environment after ingesting tissue cysts from intermediate hosts [4, 5]. Sexual reproduction occurs exclusively in the feline intestinal epithelium, leading to the production of unsporulated oocysts that are shed in feces [6]. After sporulation in the external environment (1 to 5 days), oocysts become infective and can persist for months to years under favorable conditions [7, 8].

The enteroepithelial cycle in cats begins when bradyzoites are released from tissue cysts and invade intestinal epithelial cells, where they undergo multiple rounds of asexual multiplication (schizogony) followed by gametogony and oocyst formation [9]. A single cat can shed millions of oocysts daily for 1 to 3 weeks [10]. After primary infection, cats usually develop protective immunity that limits oocyst shedding upon reexposure [11]. However, reactivation of tissue cysts in immunosuppressed cats can lead to renewed shedding [12]. Recent single-cell transcriptomic analyses have provided detailed insights into the gene expression programs driving sexual development in the feline gut [13].

Epidemiology and Transmission

T. gondii infection is distributed globally, with seroprevalence in cats varying widely by geographic region, lifestyle, and sampling methodology [14]. In urban settings, seroprevalence in privately-owned cats ranges from 10% to 40%, while community (feral) cats often exhibit higher rates exceeding 50% [15]. Molecular detection of T. gondii DNA in fecal samples from stray cats in Bangkok revealed a prevalence of 8.2% by PCR, confirming active oocyst shedding in free-roaming populations [16]. Risk factors for seropositivity in cats include outdoor access, hunting behavior, raw meat consumption, and increasing age [17]. Male cats and intact individuals also show higher odds of infection in some studies [18].

Transmission to cats occurs primarily through predation of infected intermediate hosts (rodents, birds) or ingestion of raw or undercooked meat containing tissue cysts [19]. Vertical transmission from queen to kitten has been documented but is considered rare in cats compared to other species [20]. Oocyst contamination of soil, water, and food sources facilitates infection in intermediate hosts and potentially in humans via accidental ingestion [21]. The role of migratory and opportunistic wild birds as carriers of T. gondii has been highlighted in recent work, underscoring the complexity of environmental transmission networks [22].

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic [23]. When clinical disease occurs, it most commonly manifests as nonspecific signs such as lethargy, anorexia, and fever [24]. The most frequently reported clinical syndromes are:

• Ocular toxoplasmosis: Anterior uveitis, chorioretinitis, and panophthalmitis in severe cases [25].
• Pulmonary toxoplasmosis: Dyspnea, tachypnea, and cough due to interstitial pneumonia [26].
• Hepatic toxoplasmosis: Jaundice, hepatomegaly, and elevated liver enzymes [27].
• Neurological toxoplasmosis: Seizures, ataxia, circling, behavioral changes, and cranial nerve deficits [28].

Disseminated toxoplasmosis can involve multiple organ systems and is often fatal, particularly in kittens or cats with concurrent immunosuppressive diseases such as feline leukemia virus or feline immunodeficiency virus infection [29]. Myocarditis, pancreatitis, and myositis have also been described [30]. The clinical presentation depends on the stage of infection (acute versus reactivated chronic infection) and the immune status of the host.

Pathology

Gross pathological findings in cats with acute toxoplasmosis include multifocal necrotic foci in the liver, lung, pancreas, and lymph nodes [31]. Histopathological examination reveals necrosis and inflammation with a mixed cellular infiltrate of neutrophils, macrophages, and lymphocytes. Free tachyzoites and tissue cysts containing bradyzoites can be visualized in affected tissues, particularly in the brain, retina, and skeletal muscle [32]. Pulmonary changes include alveolar septal necrosis, fibrin deposition, and edema. Neurological lesions consist of gliosis, microglial nodules, and focal necrosis with perivascular cuffing [33].

In the feline small intestine, the enteroepithelial cycle induces transient villous atrophy and epithelial cell sloughing, which is usually subclinical but may contribute to diarrhea in heavy infections [34]. The study by Zhai et al. described dynamic microRNA expression changes in the feline small intestine during T. gondii infection, revealing host-parasite interactions at the molecular level [35].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and sometimes histopathological methods. No single test is definitive for active disease.

Serological assays detect antibodies (IgG and IgM) against T. gondii. Commercial ELISA kits and indirect fluorescent antibody tests are commonly used [2]. A four-fold rise in IgG titers or detection of IgM antibodies suggests recent or active infection. However, seroconversion may occur weeks after infection, and persistent IgG titers indicate chronic infection rather than current disease [14]. Double-antigen sandwich colloidal gold immunochromatographic strips have been developed and validated for multi-species antibody detection, offering rapid point-of-care testing [2]. MIC17A has been proposed as a marker for both enteroepithelial and chronic stage infections in cats [21].

Molecular detection via PCR targeting the 529 bp repeat element or B1 gene is sensitive and specific for detecting T. gondii DNA in blood, aqueous humor, CSF, bronchoalveolar lavage fluid, or tissue biopsies [12]. Antisense PCR assays have been specifically optimized for feline samples to improve detection in low-copy-number infections [29]. Real-time quantitative PCR allows estimation of parasite burden.

Fecal examination using flotation techniques can detect oocysts, but sensitivity is low because oocyst shedding is intermittent and short-lived [16]. PCR on fecal samples is more sensitive for detecting oocyst DNA.

Histopathology with immunohistochemistry remains the gold standard for confirming tissue infection. Detection of tachyzoites in cytology preparations from effusions or aspirates can support a diagnosis of acute disseminated disease.

Imaging (thoracic radiography, ocular ultrasonography) helps characterize pulmonary and ocular lesions but is not specific.

graph TD
    A[Cat with suspected toxoplasmosis], > B{Clinical signs present?}
    B, >|Yes| C[Perform serology + PCR]
    B, >|No| D[No further testing indicated]
    C, > E{Serology IgM+ or rising IgG?}
    E, >|Yes| F[Assess organ involvement]
    E, >|No| G[Interpret as chronic exposure]
    F, > H[Ocular signs?], > I[Ophthalmoscopy + aqueous humor PCR]
    F, > J[Respiratory signs?], > K[Thoracic radiography + BAL PCR]
    F, > L[Neurologic signs?], > M[CSF analysis + brain MRI]
    I, > N[Treat with clindamycin + topical corticosteroids]
    K, > O[Treat with clindamycin]
    M, > P[Treat with clindamycin + supportive care]
    N, > Q[Monitor clinical response]
    O, > Q
    P, > Q
    Q, > R{Improvement within 7 days?}
    R, >|Yes| S[Continue treatment for 4 weeks]
    R, >|No| T[Re-evaluate diagnosis, consider other pathogens]

Treatment and Clinical Management

The goals of treatment are to control tachyzoite multiplication, reduce inflammation, and prevent tissue damage. The first-line antiprotozoal agent is clindamycin hydrochloride (10-15 mg/kg orally every 8-12 hours for 4 weeks) [23]. Alternative therapies include trimethoprim-sulfonamide combinations (15-30 mg/kg orally every 12 hours) and pyrimethamine (0.25-0.5 mg/kg orally once daily) combined with a sulfonamide [25]. Clindamycin is preferred due to its safety profile and efficacy against ocular and central nervous system infections.

Supportive care includes nutritional support (enteral feeding if anorexic), fluid therapy for dehydrated cats, and anti-inflammatory doses of corticosteroids (prednisolone 1-2 mg/kg daily) for severe ocular or neurological inflammation, provided antiprotozoal therapy is ongoing [24]. Nonsteroidal anti-inflammatory drugs should be used cautiously in cats. Prognosis is guarded for cats with disseminated or central nervous system disease, but early aggressive therapy improves outcomes.

Prevention of oocyst shedding in infected cats is not reliably achievable with current antiprotozoal drugs. Atovaquone and azithromycin have shown some effect in experimental models but are not licensed for this use in cats [3]. Gene-edited live-attenuated vaccines are under development and hold promise for reducing oocyst shedding and preventing clinical disease [3].

Zoonotic Implications and cat toxoplasmosis baby

The zoonotic risk associated with feline toxoplasmosis centers on environmental contamination with T. gondii oocysts shed by cats. Humans become infected predominantly through ingestion of sporulated oocysts from contaminated soil, water, or unwashed produce, or through consumption of undercooked meat containing tissue cysts [7]. The public health burden of toxoplasmosis is substantial, with ocular and congenital disease being major concerns [34]. In pregnant women, primary infection during gestation can lead to fetal transmission and congenital toxoplasmosis, which may result in chorioretinitis, intracranial calcifications, hydrocephalus, or neonatal death [32].

The topic of cat toxoplasmosis baby refers to the risk of vertical transmission from a pregnant woman infected through contact with cat feces. Direct transmission from an owned cat to a human is rare, as cats shed oocysts for only 1-3 weeks after primary infection and do not typically reinfect while immune [32]. However, environmental accumulation of oocysts poses a risk to seronegative pregnant women, especially those living in areas with high stray cat populations [1]. Preventive measures include avoiding litter box cleaning during pregnancy or wearing gloves and washing hands thoroughly, keeping cats indoors to reduce hunting, and feeding only cooked or commercial food.

Seroprevalence studies in veterinary personnel reveal elevated exposure risk compared to the general population, underscoring occupational hazards [6]. Social marginalization and environmental degradation have been linked to higher infection rates in informal settlements [1]. The One Health approach necessitates integrated surveillance of T. gondii in cats, wildlife, livestock, and humans to mitigate zoonotic transmission [8].

Control and Prevention Strategies

Control of feline toxoplasmosis and its zoonotic risk requires a multi-faceted strategy:

1. Reduce environmental oocyst contamination: Proper disposal of cat feces, keeping cats indoors, and discouraging stray cat populations.
2. Dietary management: Feeding only cooked or commercially processed food; preventing hunting behavior.
3. Litter box hygiene: Daily removal of feces (oocysts require 1-5 days to sporulate), disinfecting with >70°C water.
4. Vaccination: No licensed vaccine is available for cats currently, but gene-edited live-attenuated vaccines show promise in reducing oocyst shedding [3, 8].
5. Public education: Informing cat owners, pregnant women, and immunocompromised individuals about transmission risks.
6. Surveillance: Monitoring seroprevalence and oocyst shedding in cat populations to identify high-risk areas [11, 14, 27].

Feline toxoplasmosis remains a complex zoonotic disease requiring coordinated efforts between veterinarians, public health officials, and pet owners. Advances in molecular diagnostics, vaccine development, and epidemiological modeling continue to refine our understanding and management of this parasite.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[2] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[3] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[4] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[5] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[6] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[7] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[8] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[9] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[10] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[11] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[12] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[13] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[14] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[15] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[16] Tsakmakidis I, Moustakidis K, Alvanou MV et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. https://pubmed.ncbi.nlm.nih.gov/41970607/

[17] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[18] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[19] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[20] Andrade ACS, Vieira FPR, Dos Santos IC et al. Nonhuman Primates and Wild Felines as Environmental Bioindicators of Toxoplasma gondii and Leishmania spp. from a Brazilian Zoo. Vector Borne Zoonotic Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41879174/

[21] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[22] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[23] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[24] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[25] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[26] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41747478/

[27] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[28] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[29] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[30] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[31] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[32] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[33] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[34] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[35] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/